Type Coisogenic; Mutant Strain; Transgenic; Additional information on Genetically Engineered and Mutant Mice. Visit our online Nomenclature tutorial. Species laboratory mouse Generation N12pN1
Generation DefinitionsDonating Investigator Monique E De Paepe, Women and Infants Hospital Description
Mice hemizygous for the (tetOp)7-FasL transgene (TetOp-FasL transgenic mice) are viable and fertile with no reported phenotypic abnormalities. The (tetOp)7-FasL transgene has the Tet response element (TRE or tetO) upstream of a murine Fas ligand (FasL) coding sequence. When bred with other mice expressing tetracycline-controlled transactivator protein (tTA) or reverse tetracycline-controlled transactivator protein (rtTA), FasL overexpression in the resulting double mutant offspring can be regulated with tetracycline or its analog doxycycline (dox). FasL overexpression leads to Fas/FasL receptor-mediated death-signaling pathway activation and results in cell apoptosis. The donating investigator reports that transgenic mice from founder line B (TetOp-FasL transgenic line B) exhibit very high FasL overexpression levels in the presence of rtTA and 0.01 mg/ml Dox (low FasL levels are achievable by titrating Dox even lower). The donating investigator reports that TetOp-FasL transgenic line B mice exhibit "none-to-very-very-minimal" transgenic FasL expression in the absence of tTA or rtTA+Dox.Mice harboring the (tetOp)7-FasL transgene allow Tet-Off/Tet-On expression of FasL, and are a tool for temporal regulation of apoptotic cell death in specific tissue/cell types (via inducible FasL overexpression and subsequent activation of the Fas/FasL receptor-mediated death-signaling pathway).
For example, when TetOp-FasL transgenic line B mice are bred to a strain expressing rtTA in developing/adult lung and respiratory epithelium (CCSP-rtTA; Stock No. 006222), the resulting double transgenic mice (CCSP-rtTA/[tetOp]7-FasL) allow dox-inducible FasL-overexpression in respiratory epithelium and are a model for neonatal lung injury and bronchopulmonary dysplasia (BPD). Following dox administration to pregnant or nursing dams, CCSP-rtTA/[tetOp]7-FasL neonatal mice exhibit increased alveolar epithelial apoptosis induced by FasL overexpression that results in BPD-like disrupted alveolar remodeling.Development
The (tetOp)7-FasL transgene was designed in the laboratory of Dr. Monique E. De Paepe (Women and Infants Hospital, Providence, Rhode Island) with a Tet response element (TRE) upstream of the 943 bp murine Fas ligand (FasL) coding sequence, all followed by a bovine growth hormone intron and polyA sequence. The Tet response element (TRE) contains seven copies of the 42-bp tet operator sequence (tetO) just upstream of a minimal CMV promoter. The 2.9 kbp (tetOp)7-FasL transgene was injected into fertilized FVB/N oocytes. Founder mice from line B were found to contain ~6 copies of the transgene and high levels of doxycycline-induced FasL mRNA up-regulation. These founder mice were bred with FVB/NTac wildtype mice for 12-13 generations prior to sending to The Jackson Laboratory Repository. Upon arrival, TetOp-FasL transgenic line B mice were bred to FVB/NJ inbred mice (Stock No. 001800) for at least one generation to establish the colony.
| Control | ||
|---|---|---|
| Noncarrier | ||
| 001800 FVB/NJ | ||
| Considerations for Choosing Controls | ||
Strains carrying other alleles of Fasl
001021 B6Smn.C3-Faslgld/J 000784 C3H/HeJ-Faslgld/J 002932 CPt.C3-Faslgld/J 003499 NOD-Tg(Ins2-Fasl)24Ach 008223 NOD.C3(B6)-Faslgld /LwnJ View Strains carrying other alleles of Fasl (5 strains)
Strains carrying other alleles of tetO
008079 129S-Ppargtm2Yba/J 016176 B6(Cg)-Tg(tetO-Per2)2Jt/J 009602 B6.129S4(Cg)-Kcnn2tm2Jpad/J 009603 B6.129S4-Kcnn3tm1Jpad/J 017983 B6.Cg-Col1a1tm9(tetO-Dnmt3b*)Jae Gt(ROSA)26Sortm1(rtTA*M2)Jae/J 014588 B6.Cg-Gt(ROSA)26Sortm1(rtTA*M2)Jae Col1A1tm6(tetO-MSI2)Jae/J 014648 B6.Cg-Gt(ROSA)26Sortm37(H1/tetO-RNAi:Taz)Arte/ZkhuJ 006361 B6.Cg-Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/J 016998 B6.Cg-Tg(TetO-Axin1,EGFP)TA6Cos/J 003762 B6.Cg-Tg(tetFosb)4468Nes/J 007051 B6.Cg-Tg(tetO-APPSwInd)102Dbo/Mmjax 007052 B6.Cg-Tg(tetO-APPSwInd)107Dbo/Mmjax 007049 B6.Cg-Tg(tetO-APPSwInd)885Dbo/Mmjax 007618 B6.Cg-Tg(tetO-Arntl)1Jt/J 017555 B6.Cg-Tg(tetO-CALY)5Cber/J 008277 B6.Cg-Tg(tetO-Clockm1Jt)CL57Jt/J 008468 B6.Cg-Tg(tetO-DTA)1Gfi/J 017791 B6.Cg-Tg(tetO-Hamp)2181Nca/J 009344 B6.Cg-Tg(tetO-Ifng)184Pop/J 009136 B6.Cg-Tg(tetO-Kcnj2,lacZ)1Gogo/J 013583 B6.Cg-Tg(tetO-LRRK2)C7874Cai/J 020652 B6.Cg-Tg(tetO-Mif)279Aren/J 017331 B6.Cg-Tg(tetO-Ppp3ca*)11255Kndl/J 017332 B6.Cg-Tg(tetO-Ppp3ca*)13967Kndl/J 017330 B6.Cg-Tg(tetO-TAg*)175Kndl/J 006234 B6.Cg-Tg(tetO-cre)1Jaw/J 005738 B6.FVB-Tg(tetO-EGFP,-Tgfbr2)8Mcle/J 006911 B6;129-Gt(ROSA)26Sortm1(rtTA*M2)Jae Col1a1tm2(tetO-Pou5f1)Jae/J 011001 B6;129S4-Col1a1tm1(tetO-Pou5f1,-Klf4,-Sox2,-Myc)Hoch/J 016836 B6;129S4-Gt(ROSA)26Sortm1(rtTA*M2)Jae Col1a1tm7(tetO-HIST1H2BJ/GFP)Jae/J 012433 B6;C3-Tg(ACTA1-rtTA,tetO-cre)102Monk/J 002709 B6;C3-Tg(TettTALuc)1Dgs/J 016841 B6;C3-Tg(tetO-TARDBP)12Vle/J 014650 B6;C3-Tg(tetO-TARDBP*)4Vle/J 012450 B6;D2-Tg(tetO-SNCA)1Cai/J 008344 B6;DBA-Tg(Fos-tTA,Fos-EGFP*)1Mmay Tg(tetO-lacZ,tTA*)1Mmay/J 008082 B6;SJL-Tg(Tagln-tTA)1Mrab Tg(tetO-Mcpt1)1Mrab/J 010575 B6;SJL-Tg(tetO-Egfr*)2-9Jek/J 010577 B6;SJL-Tg(tetO-Erbb2*)8-4Jek/J 002621 B6;SJL-Tg(tetop-lacZ)2Mam/J 006004 B6C3-Tg(tetO-APPSwInd)885Dbo/Mmjax 016976 B6C3-Tg(tetO-SNCA*A53T)33Vle/J 018913 B6N.Cg-Tg(tetO-GFP,-lacZ)G3Rsp/J 006244 C.Cg-Tg(tetO-cre)1Jaw/J 017719 C3HeB/FeJ-Tg(tetO-TAg)1Efr/J 017955 C57BL/6-Tg(Gfap-rtTA,tetO-MAOB,-lacZ)1Jkan/J 005706 C57BL/6-Tg(tetO-CDK5R1/GFP)337Lht/J 006618 C57BL/6-Tg(tetO-COX8A/EYFP)1Ksn/J 017613 C57BL/6-Tg(tetO-Cdkn1b)1Scpr/J 013729 C57BL/6-Tg(tetO-EDN1,-lacZ)9Mhus/J 010713 C57BL/6-Tg(tetO-GFP/tetX)5696Stl/J 013728 C57BL/6-Tg(tetO-NOS2,-lacZ)240iMhus/J 016181 C57BL/6-Tg(tetO-Nr1d1)1Schb/J 008278 C57BL/6J-Tg(tetO-Clock)1Jt/J 021065 FVB(C)-Tg(tetO-Npc1/YFP)1Mps/J 017542 FVB-Tg(Myh6/tetO-ATP2B4)1Jmol/J 016571 FVB-Tg(Myh6/tetO-Gata6)2Jmol/J 014155 FVB-Tg(Myh6/tetO-Itpr1)22.3Jmol/J 014153 FVB-Tg(Myh6/tetO-Itpr2)3.11Jmol/J 014154 FVB-Tg(Myh6/tetO-Itpr2)4.9Jmol/J 012684 FVB-Tg(Myh6/tetO-POSTN)22.1Jmol/J 010580 FVB-Tg(Myh6/tetO-PRKCA*)1Jmk/J 013156 FVB-Tg(tetO-CDK5R1*)1Vln/J 013777 FVB-Tg(tetO-Cacna1g)1Jmol/J 013778 FVB-Tg(tetO-Cacnb2)1Jmol/J 013779 FVB-Tg(tetO-Cacnb2)2Jmol/J 013780 FVB-Tg(tetO-Cib1)1Jmol/J 010578 FVB-Tg(tetO-Dusp6)1Jmol/J 017333 FVB-Tg(tetO-Gnai2*,-lacZ)382Kndl/J 008685 FVB-Tg(tetO-Kdr*)4377.5Rwng/J 015815 FVB-Tg(tetO-MAPT*P301L)#Kha/JlwsJ 008695 FVB-Tg(tetO-MET)23Rwng/J 012387 FVB-Tg(tetO-Ppargc1a)1Dpk/J 012385 FVB-Tg(tetO-Ppargc1b)7Dpk/J 006439 FVB-Tg(tetO/CMV-KRAS*G12C)9.1Msmi/J 008244 FVB.Cg-Tg(tetO-cre)1Jaw/J 012459 FVB/N-Tg(Myh6*/tetO-Capn1)L2Gwd/J 005941 FVB/N-Tg(tetO-Aurkb,lacZ)41Kra/J 006202 FVB/N-Tg(tetO-BCR/ABL1)2Dgt/J 019376 FVB/N-Tg(tetO-MYC)36aBop/J 003315 FVB/N-Tg(tetORo1-lacZ)3Conk/J 005076 NOD.Cg-Tg(tetO-EGFP/FADD)1Doi/DoiJ 006999 STOCK Dbttm1Geh Tg(Cebpb-tTA)5Bjd Tg(tetO-DBT)A1Geh/J 011004 STOCK Gt(ROSA)26Sortm1(rtTA*M2)Jae Col1a1tm3(tetO-Pou5f1,-Sox2,-Klf4,-Myc)Jae/J 011011 STOCK Gt(ROSA)26Sortm1(rtTA*M2)Jae Col1a1tm4(tetO-Pou5f1,-Sox2,-Klf4,-Myc)Jae/J 011013 STOCK Gt(ROSA)26Sortm1(rtTA*M2)Jae Col1a1tm5(tetO-Pou5f1,-Klf4,-Myc)Jae/J 018999 STOCK Gt(ROSA)26Sortm1(tTA,tetO-Mir155)Fjsl/J 017596 STOCK Gt(ROSA)26Sortm1.1(rtTA,EGFP)Nagy Smn1tm1Msd Tg(SMN2)89Ahmb Tg(SMN2*delta7)4299Ahmb Tg(tetO-SMN2,-luc)#aAhmb/J 017597 STOCK Gt(ROSA)26Sortm1.1(rtTA,EGFP)Nagy Smn1tm1Msd Tg(SMN2)89Ahmb Tg(SMN2*delta7)4299Ahmb Tg(tetO-SMN2,-luc)#bAhmb/J 015838 STOCK Tg(Camk2a-tTA)1Mmay Tg(tetO-ABL1*P242E*P249E)CPdav/J 008755 STOCK Tg(Ins2-rtTA)2Efr Tg(teto-DTA)1Gfi/J 012477 STOCK Tg(Myh6*/tetO-GCaMP2)1Mik/J 016572 STOCK Tg(Myh6/tetO-Gata4)1Jmol/J 014544 STOCK Tg(tetO-ABL1*P242E*P249E)CPdav/J 014093 STOCK Tg(tetO-CHRM3*)1Blr/J 008790 STOCK Tg(tetO-DISC1*)1001Plet/J 008168 STOCK Tg(tetO-DTA)1Gfi/J 017755 STOCK Tg(tetO-GCAMP2)12iRyu/J 005104 STOCK Tg(tetO-HIST1H2BJ/GFP)47Efu/J 005699 STOCK Tg(tetO-Ipf1,EGFP)956.6Macd/J 005728 STOCK Tg(tetO-Ipf1,lacZ)958.1Macd/J 012441 STOCK Tg(tetO-LRRK2*G2019S)E3Cai/J 017599 STOCK Tg(tetO-SMN2,-luc)#aAhmb/J 017600 STOCK Tg(tetO-SMN2,-luc)#bAhmb/J 012442 STOCK Tg(tetO-SNCA*A53T)E2Cai/J 006224 STOCK Tg(tetO-cre)1Jaw/J 017906 STOCK Tg(tetO-hop/EGFP,-COP4/mCherry)6Kftnk/J 012345 STOCK Tg(tetO-tdTomato,-Syp/EGFP*)1.1Luo/J 012449 STOCK Tg(teto-LRRK2)C7874Cai/J View Strains carrying other alleles of tetO (109 strains)
Tet Expression Systems
View Related Disease (OMIM) Terms
Related Disease (OMIM) Terms provided by MGI
- Potential model based on transgenic expression of a human gene that is associated with this disease. Phenotypic similarity to the human disease has not been tested. Lung Cancer (FASLG)
View Research Applications
Research Applications
This mouse can be used to support research in many areas including:
Apoptosis Research
Endogenous Regulators
Cell Biology Research
Signal Transduction
Immunology, Inflammation and Autoimmunity Research
Intracellular Signaling Molecules
Neurobiology Research
Tet Expression System
tTA/rtTA Responsive Strains
Research Tools
Apoptosis Research
Cancer Research
Tetop Tet System
Cardiovascular Research
Tetop Tet System
Genetics Research
Mutagenesis and Transgenesis: Tetop Tet System
Neurobiology Research
Tetop Tet System
Reproductive Biology Research
Tetop Tet System
Tet Expression Systems
tTA/rtTA Responsive Strains
| Allele Symbol | Tg(tetO-Fasl)BDepa | ||
|---|---|---|---|
| Allele Name | transgene insertion B, Monique De Paepe | ||
| Allele Type | Transgenic (random, expressed) | ||
| Common Name(s) | (tetOp)7-FasL transgenic line B; TetOp-FasL transgenic line B; | ||
| Mutation Made By | Monique De Paepe, Women and Infants Hospital | ||
| Strain of Origin | FVB/N | ||
| Expressed Gene | Fasl, Fas ligand (TNF superfamily, member 6), mouse, laboratory | ||
| Promoter | tetO, tet operator, | ||
| Molecular Note | The (tetO)7-FasL transgene was designed with a Tet response element (TRE) upstream of the 943 bp murine Fas ligand (FasL) coding sequence, all followed by a bovine growth hormone intron and polyA sequence. The Tet response element (TRE) contains seven copies of the 42-bp tet operator sequence (tetO) just upstream of a minimal CMV promoter. Five founder lines (A-E) were established. Founder mice from line B were found with ~6 copies of the transgene and high levels of doxycycline-induced FasL mRNA up-regulation. [MGI Ref ID J:137382] | ||
Genotyping Protocols
Tg(tetO-Fasl)BDepa, Melt Curve Analysis
Tg(tetO-Fasl)BDepa, Standard PCR
Helpful Links
Genotyping resources and troubleshooting
De Paepe ME; Gundavarapu S; Tantravahi U; Pepperell JR; Haley SA; Luks FI; Mao Q. 2008. Fas-ligand-induced apoptosis of respiratory epithelial cells causes disruption of postcanalicular alveolar development. Am J Pathol 173(1):42-56. [PubMed: 18535181] [MGI Ref ID J:137382]
De Paepe ME; Mao Q; Ghanta S; Hovanesian V; Padbury JF. 2011. Alveolar epithelial cell therapy with human cord blood-derived hematopoietic progenitor cells. Am J Pathol 178(3):1329-39. [PubMed: 21356383] [MGI Ref ID J:169681]
Tg(tetO-Fasl)BDepa relatedde Paepe ME; Haley SA; Lacourse Z; Mao Q. 2010. Effects of Fas-ligand overexpression on alveolar type II cell growth kinetics in perinatal murine lungs. Pediatr Res 68(1):57-62. [PubMed: 20375852] [MGI Ref ID J:174046]
Animal Health Reports
Production of mice from cryopreserved embryos or sperm occurs in a maximum barrier room, G200.Colony Maintenance
Breeding & Husbandry When maintaining a live colony, hemizygous mice may be bred to wildtype siblings or to FVB/NJ inbred mice (Stock No. 001800). The donating investigator has not tried to generate homozygous mice.
| Pricing for USA, Canada and Mexico shipping destinations |
|
Cryopreserved Mice - Ready for Recovery
Animals Provided
Price (US dollars $) Cryorecovery* $2250.00 At least two mice that carry the mutation (if it is a mutant strain) will be provided. Their genotypes may not reflect those discussed in the strain description. Please inquire for possible genotypes and see additional details below.
Standard Supply
Cryopreserved. Ready for recovery. Please refer to pricing and supply notes on the strain data sheet for further information.
Supply Notes
- Cryorecovery - Standard.
Progeny testing is not required.
The average number of mice provided from recovery of our cryopreserved strains is 10. The total number of animals provided, their gender and genotype will vary. We will fulfill your order by providing at least two pair of mice, at least one animal of each pair carrying the mutation of interest. Please inquire if larger numbers of animals with specific genotype and genders are needed. Animals typically ship between 11 and 14 weeks from the date of your order. If a second cryorecovery is needed in order to provide the minimum number of animals, animals will ship within 25 weeks. IMPORTANT NOTE: The genotypes of animals provided may not reflect the mating scheme utilized by The Jackson Laboratory prior to cryopreservation, or that discussed in the strain description. Please inquire about possible genotypes which will be recovered for this specific strain. The Jackson Laboratory cannot guarantee the reproductive success of mice shipped to your facility. If the mice are lost after the first three days (post-arrival) or do not produce progeny at your facility, a new order and fee will be necessary.Cryorecovery to establish a Dedicated Supply for greater quantities of mice.
Mice recovered can be used to establish a dedicated colony to contractually supply you mice according to your requirements. Price by quotation. For more information on Dedicated Supply, please contact JAX® Services, Tel: 1-800-422-6423 (from U.S.A., Canada or Puerto Rico only) or 1-207-288-5845 (from any location).
| Pricing for International shipping destinations |
|
Cryopreserved Mice - Ready for Recovery
Animals Provided
Price (US dollars $) Cryorecovery* $2925.00 At least two mice that carry the mutation (if it is a mutant strain) will be provided. Their genotypes may not reflect those discussed in the strain description. Please inquire for possible genotypes and see additional details below.
Standard Supply
Cryopreserved. Ready for recovery. Please refer to pricing and supply notes on the strain data sheet for further information.
Supply Notes
- Cryorecovery - Standard.
Progeny testing is not required.
The average number of mice provided from recovery of our cryopreserved strains is 10. The total number of animals provided, their gender and genotype will vary. We will fulfill your order by providing at least two pair of mice, at least one animal of each pair carrying the mutation of interest. Please inquire if larger numbers of animals with specific genotype and genders are needed. Animals typically ship between 11 and 14 weeks from the date of your order. If a second cryorecovery is needed in order to provide the minimum number of animals, animals will ship within 25 weeks. IMPORTANT NOTE: The genotypes of animals provided may not reflect the mating scheme utilized by The Jackson Laboratory prior to cryopreservation, or that discussed in the strain description. Please inquire about possible genotypes which will be recovered for this specific strain. The Jackson Laboratory cannot guarantee the reproductive success of mice shipped to your facility. If the mice are lost after the first three days (post-arrival) or do not produce progeny at your facility, a new order and fee will be necessary.Cryorecovery to establish a Dedicated Supply for greater quantities of mice.
Mice recovered can be used to establish a dedicated colony to contractually supply you mice according to your requirements. Price by quotation. For more information on Dedicated Supply, please contact JAX® Services, Tel: 1-800-422-6423 (from U.S.A., Canada or Puerto Rico only) or 1-207-288-5845 (from any location).
|
|
Cryopreserved. Ready for recovery. Please refer to pricing and supply notes on the strain data sheet for further information.
| Control | ||
|---|---|---|
| Noncarrier | ||
| 001800 FVB/NJ | ||
| Considerations for Choosing Controls | ||
| Control Pricing Information for Genetically Engineered Mutant Strains. | ||
For Licensing and Use Restrictions view the link(s) below:
- Use of MICE by companies or for-profit entities requires a license prior to shipping.
| phone: | 207-288-6470 |
| fax: | 207-288-6655 |
MICE, PRODUCTS AND SERVICES ARE PROVIDED “AS IS”. JACKSON EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESS, IMPLIED, OR STATUTORY, WITH RESPECT TO MICE, PRODUCTS OR SERVICES, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR ANY WARRANTY OF NON-INFRINGEMENT OF ANY PATENT, TRADEMARK, OR OTHER INTELLECTUAL PROPERTY RIGHTS.
In case of dissatisfaction for a valid reason and claimed in writing by a purchaser within ninety (90) days of receipt of mice, products or services, JACKSON will, at its option, provide credit or replacement for the mice or product received or the services provided.
In no event shall JACKSON, its trustees, directors, officers, employees, and affiliates be liable for any causes of action or damages, including any direct, indirect, special, or consequential damages, arising out of the provision of MICE, PRODUCTS or services, including economic damage or injury to property and lost profits, and including any damage arising from acts or negligence on the part of JACKSON, its agents or employees. Unless prohibited by law, in purchasing or receiving MICE, PRODUCTS or services from JACKSON, purchaser or recipient, or any party claiming by or through them, expressly releases and discharges JACKSON from all such causes of action or damages, and further agrees to defend and indemnify JACKSON from any costs or damages arising out of any third party claims.
MICE and PRODUCTS are to be used in a safe manner and in accordance with all applicable governmental rules and regulations.
The foregoing represents the General Terms and Conditions applicable to JACKSON’s MICE, PRODUCTS or services. In addition, special terms and conditions of sale of certain MICE, PRODUCTS or services may be set forth separately in JACKSON web pages, catalogs, price lists, contracts, and/or other documents, and these special terms and conditions shall also govern the sale of these MICE, PRODUCTS and services by JACKSON, and by its licensees and distributors.
Acceptance of delivery of MICE, PRODUCTS or services shall be deemed agreement to these terms and conditions. No purchase order or other document transmitted by purchaser or recipient that may modify the terms and conditions hereof, shall be in any way binding on JACKSON, and instead the terms and conditions set forth herein, including any special terms and conditions set forth separately, shall govern the sale of MICE, PRODUCTS or services by JACKSON.